Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer

Metastatic triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Combination of systemic chemotherapy and immune checkpoint blockade is effective but of limited benefit due to insufficient intratumoral infiltration of cytotoxic T lymphocytes (CTLs) and the accumulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Chao, Zhang, Wen, Wang, Jinming, Zhai, Yihui, Xiong, Fengqin, Cai, Ying, Gong, Xiang, Zhu, Binyu, Zhu, Helen He, Wang, Hao, Li, Yaping, Zhang, Pengcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513558/
https://www.ncbi.nlm.nih.gov/pubmed/36176911
http://dx.doi.org/10.1016/j.apsb.2022.02.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513558/
https://www.ncbi.nlm.nih.gov/pubmed/36176911
http://dx.doi.org/10.1016/j.apsb.2022.02.021

Ejemplares similares